Overview
M Fedulova practices practicing medicine in Moscow, Russian Federation.
Their clinical expertise encompasses Adult T-Cell Leukemia and Sudden Infant Death Syndrome (SIDS).
They are actively involved in clinical research, co-authoring 22 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about M V. Fedulova
Is M V. Fedulova a top-rated expert for Adult T-Cell Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. M V. Fedulova is classified as an Experienced expert for Adult T-Cell Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does M V. Fedulova participate in research or clinical trials?
Yes. M V. Fedulova has published 22 articles and abstracts on conditions like Adult T-Cell Leukemia. You can view a list of M V. Fedulova's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adult T-Cell LeukemiaFedulova isExperienced. Learn about Adult T-Cell Leukemia.
- Sudden Infant Death Syndrome (SIDS)Fedulova isExperienced. Learn about Sudden Infant Death Syndrome (SIDS).